Inhibrx Biosciences INBX
NASDAQ INBX
$98.86 +3.56 (+3.74%)
As of: Oct 21, 2026 · 2:45 PM EDT

Inhibrx Biosciences (INBX) Common Stock Issued (2023 - 2025)

Updated

Analysis

Inhibrx Biosciences (INBX) Common Stock Issued (2023 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Issued (Qtr)
1 Eli Lilly 1,136.71 Bn 1,105.29 Bn 19.71 Bn -
2 Johnson & Johnson 617.55 Bn 536.07 Bn 17.26 Bn 359.00 Mn
3 AbbVie 501.02 Bn 474.13 Bn 12.70 Bn -
4 Merck 368.18 Bn 322.56 Bn 12.21 Bn 43.00 Mn
5 Novartis Ag 297.89 Bn 261.88 Bn 11.24 Bn -
6 Astrazeneca 261.33 Bn 235.02 Bn 12.86 Bn 6.00 Mn
7 Amgen 236.60 Bn 191.99 Bn 7.24 Bn -
8 Gilead Sciences 190.55 Bn 164.75 Bn 6.22 Bn 9.00 Mn
9 Pfizer 169.77 Bn 116.42 Bn 10.94 Bn -
10 Inhibrx Biosciences 1.55 Bn 951.77 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 1.25 Mn
Sep 30, 2025 352,000.00
Jun 30, 2024 32.95 Mn
Mar 31, 2024 38.73 Mn
Dec 31, 2023 1.09 Mn
Sep 30, 2023 200.02 Mn
API Access

Inhibrx Biosciences Common Stock Issued API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-stock-issued&ticker=INBX&period=max&api_key=YOUR_API_KEY